These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 7223599

  • 1. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
    Hamer A, Peter T, Platt M, Mandel WJ.
    Am Heart J; 1981 May; 101(5):600-12. PubMed ID: 7223599
    [Abstract] [Full Text] [Related]

  • 2. Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome.
    Chazov EI, Shugushev KK, Rosenshtraukh LV.
    Am Heart J; 1984 Sep; 108(3 Pt 1):475-82. PubMed ID: 6382988
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Verapamil in the study and treatment of supraventricular tachycardias, with special reference to pre-excitation].
    Krikler DM.
    Minerva Med; 1975 May 26; 66(39):1914-22. PubMed ID: 236526
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
    Chen SA, Chiang CE, Tai CT, Lee SH, Chiou CW, Ueng KC, Wen ZC, Cheng CC, Chang MS.
    Circulation; 1996 Jun 01; 93(11):2023-32. PubMed ID: 8640978
    [Abstract] [Full Text] [Related]

  • 10. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK, Prasad GS, Mohan JC, Arora R, Khalilullah M.
    Indian Heart J; 1991 Jun 01; 43(1):5-10. PubMed ID: 1894303
    [Abstract] [Full Text] [Related]

  • 11. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia.
    Sakurai M, Yasuda H, Kato N, Nomura A, Fujita M, Nishino T, Fujita K, Koike Y, Saito H.
    Am Heart J; 1983 Apr 01; 105(4):619-28. PubMed ID: 6837416
    [Abstract] [Full Text] [Related]

  • 12. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW, Whitford E, Middlebrook K, Federman J, Anderson S, Pitt A.
    Am J Cardiol; 1982 Dec 01; 50(6):1323-30. PubMed ID: 7148709
    [Abstract] [Full Text] [Related]

  • 13. Effects of verapamil on accessory pathway properties and induction of circus movement tachycardia in patients with the Wolf-Parkinson-White syndrome.
    Matsuyama E, Konishi T, Okazaki H, Matsuda H, Kawai C.
    J Cardiovasc Pharmacol; 1981 Dec 01; 3(1):11-24. PubMed ID: 6160340
    [Abstract] [Full Text] [Related]

  • 14. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
    Hammill SC, McLaran CJ, Wood DL, Osborn MJ, Gersh BJ, Holmes DR.
    J Am Coll Cardiol; 1987 Jun 01; 9(6):1364-8. PubMed ID: 3584724
    [Abstract] [Full Text] [Related]

  • 15. Effect of verapamil on retrograde conduction in atrioventricular nodal reentrant tachycardia.
    Reddy CP, McAllister RG.
    Am J Cardiol; 1984 Sep 01; 54(6):535-43. PubMed ID: 6475770
    [Abstract] [Full Text] [Related]

  • 16. The use of calcium gluconate prior to verapamil in infants with paroxysmal supraventricular tachycardia.
    Roguin N, Shapir Y, Blazer S, Zeltzer M, Berant M.
    Clin Cardiol; 1984 Nov 01; 7(11):613-6. PubMed ID: 6499292
    [Abstract] [Full Text] [Related]

  • 17. Concealed pre-excitation causing paroxysmal reciprocating atrioventricular tachycardia in infancy.
    Hallidie-Smith KA, Krikler D, Mithchell A.
    Arch Dis Child; 1978 Aug 01; 53(8):668-73. PubMed ID: 708105
    [Abstract] [Full Text] [Related]

  • 18. [Wolff-Parkinson-White syndrome with orthodromic supraventricular tachycardia associated with a "hyper-conductor" atrio-ventricular node. A therapeutic challenge].
    Hernández González D, Iturralde Torres P, Romero L, Colín L, Villarreal A, González Hermosillo JA.
    Arch Inst Cardiol Mex; 1990 Aug 01; 60(2):175-81. PubMed ID: 2378538
    [Abstract] [Full Text] [Related]

  • 19. Effects of intravenous diltiazem administration in patients with inducible tachycardia.
    Waleffe A, Hastir F, Kulbertus HE.
    Eur Heart J; 1985 Oct 01; 6(10):882-90. PubMed ID: 4076199
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias.
    Abdollah H, Brugada P, Green M, Wehr M, Wellens HJ.
    Am J Cardiol; 1984 Sep 01; 54(6):544-9. PubMed ID: 6433688
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.